| CPC A61B 18/042 (2013.01) [A61B 8/0841 (2013.01); A61B 18/04 (2013.01); A61B 2018/00005 (2013.01); A61B 2018/00011 (2013.01); A61B 2018/00017 (2013.01); A61B 2018/00023 (2013.01); A61B 2018/00101 (2013.01); A61B 2018/00547 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00642 (2013.01); A61B 2018/00702 (2013.01); A61B 2018/00744 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/00821 (2013.01); A61B 2018/044 (2013.01); A61B 2018/048 (2013.01); A61B 2090/378 (2016.02); A61B 2090/3784 (2016.02); A61B 2218/007 (2013.01)] | 20 Claims |

|
1. A method of treatment, comprising:
inserting a vapor delivery needle into a tissue of a peripheral zone of a prostate, the tissue of the peripheral zone including a cancer lesion; and
delivering an amount of vapor from the vapor delivery needle to the tissue of the peripheral zone, wherein the amount of vapor is configured to ablate all tissue comprising the peripheral zone of the tissue.
|